An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn MoreAbout mild for Patients
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAbout mild for Healthcare Professionals
A Mild Procedure with Proven Results 📈
In a study performed at the @clevelandclinic, the Mild Procedure for lumbar spinal stenosis (#LSS) helped 88% of patients avoid back surgery for at least 5 years while providing lasting relief.*
*View clinical data and the Mild Procedure’s extensive body of evidence at the 🔗 link in bio.
See how Dr. Aaron Calodney from @precisionspinecare gets his lumbar spinal stenosis (#LSS) patients back to their favorite things by making the #MOVE2mild.
With an 85% patient satisfaction rate, studies show that the Mild Procedure continues to improve patient functionality over time.*
View the case study for this patient, along with others from leading interventional pain management physicians, at the 🔗 link in bio.
*Clinical data available at the 🔗 link in bio.
During this season of gratitude, we are thankful for the dedicated healthcare providers and staff who work tirelessly to help patients reclaim their quality of life.
We are also grateful to our #TeamVertos colleagues for their unwavering commitment to offer safe, effective solutions to the lumbar spinal stenosis (#LSS) community.
Wishing everyone a wonderful Thanksgiving filled with friends, family, health, and happiness.
Our company is growing! We`re delighted to introduce the latest additions to #TeamVertos. Help us welcome our new Director of Patient Advocacy, Michelle Torr, Director of HCP Marketing & Patient Education, Linh Ho, Upstream Product Manager, Kevin Serocke, District Sales Managers, Chase Matson and Mike Vanek, and Clinical Specialists, Christine Baijnath, Mark Nieves, and Will Nowesnick.
We’re glad to have you on the team. Welcome to Vertos!
Interested in joining our team? Click the 🔗 link in bio for employment opportunities.
What an incredible experience at the ASRA (@asra_society) Annual Pain Medicine Meeting! Thank you to everyone who made this gathering a hub of innovation and collaboration. Your commitment to advancing pain medicine is truly inspiring. #ASRA2023
#ChronicLowBackPain #MOVE2mild #MobilityMatters #KnowYourBackStory #LookForTheLigament #Vertos #interventionalpain #painmedicine #minimallyinvasive #paincare #lumbarspinalstenosis #stenosis #spinalstenosis #lumbarstenosis #painphysician #paindoctor #steroidinjection #spineexpert #epiduralsteroidinjection #epiduralsteroidinjections #lumbardecompression #steroidinjections #painphysicians #chronicbackpain #painmanagement #interventionalpainphysician #LSStreatment #VertosMedical
For patients with lumbar spinal stenosis (#LSS), daily activities like standing or walking can be a source of pain and discomfort. Help your patients increase their mobility with the Mild Procedure.
Clinical data has shown that with Mild, average standing time over one year improved from 8 min. to 56 min. and average walking distance increased from 246 ft. to 3,956 ft. with less pain.*
*View clinical data and the Mild Procedure’s robust body of evidence at the 🔗 link in bio.
We are #hiring and excited about growing #TeamVertos with new career opportunities. Join us on our mission to help lumbar spinal stenosis (#LSS) patients get on the path to lasting relief.
View current openings available throughout the U.S. and apply online at the link 🔗 in bio.
Vertos Medical is an Equal Employment Opportunity employer.
#NowHiring #JoinOurTeam #MedicalDeviceJobs #MedicalDevices
Vertos Medical is thrilled to announce that it ranked 370 on the 2023 Deloitte Technology Fast 500 list, a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. The Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2019 to 2022.
This is the 2nd consecutive year that Vertos has received this award!
To read more, including a quote from our CEO Eric Wichems, view the full press release at the link 🔗 in bio.
Thank you to the New York & New Jersey Pain Medicine Congress for an incredible gathering of minds and cutting-edge insights into the world of pain management.
Join us in congratulating Dr. Sean Li (@sxl08md), who has been honored with the Outstanding Pain Physician Award of 2023! His dedication to improving the lives of countless patients is truly remarkable.
Special recognition goes to Dr. Stanley Golovac (@stangolovac) for his exceptional presentation on the safety and effectiveness of the Mild Procedure for treating lumbar spinal stenosis (#LSS).
We`re equally thankful to the dynamic duo of Drs. Stanley Golovac and Harry Sukumaran (@harrysukumaran) for leading the Mild Lab Station at the NYNJSIPP Cadaver Workshop, a hands-on experience that is evolving advanced pain medicine therapies. #MOVE2mild
Two new articles featuring the Mild Procedure for lumbar spinal stenosis (LSS)! Idaho Press (@idahopress) recently highlighted spine health awareness by sharing the signs, symptoms, & prevalence of LSS, and how Mild may offer hope and relief for patients looking for minimally invasive treatment options.
In an article from Saint Luke`s Health System (@saintlukeskc), read about a retired physician who finally achieved relief and gained mobility after living with low back pain for more than a decade. After the Mild Procedure he said, “The difference was remarkable.”
View the stories and other recent articles at the 🔗 link in bio.
The Mild Insights Hub for APPs empowers advanced practice providers to efficiently identify & manage patients in their practice, who may be candidates for the Mild Procedure.
Visit our comprehensive library to learn how to get more patients on the path to lasting relief, including patient profiles, treatment planning, educational resources, and APP essential topics.
To explore the content library, visit the 🔗 link in bio.
When epidural steroid injections (ESIs) fail to provide relief for patients suffering from lumbar spinal stenosis (#LSS), the Mild Procedure can help. By removing excess ligament tissue, this minimally invasive procedure addresses a major root cause of LSS by restoring space in the spinal canal.
Level 1 study data has shown that Mild has a safety profile equivalent to an ESI, but with lasting results.*
*View clinical data and the Mild Procedure’s robust body of evidence at the 🔗 link in bio.
Thank you to all the incredible physicians, advanced practice providers (APPs), and faculty who joined us at the Business of Pain Medicine Annual Conference. The education, expertise, and passion for advancing patient care made the event a definitive one to remember.
A special thank you to Dr. Sean Li and Patrick McGinn, PA-C, for their leadership in delivering a captivating lunch symposium, shedding light on how the Mild Procedure can empower APPs to enhance both the efficiency and ultimately, the quality of patient care.
The Mild Insights Hub helps to educate, inform, and raise awareness around the Mild Procedure for Interventional Pain Management physicians, as well as those in referring practices.
Visit the Physician section of the Mild Insights Hub today to discover clinical pearls, Mild data, practice integration tips, and helpful patient profiles.
Explore the content at the 🔗 link in bio.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary at knowyourbackstory.com.
Deer TR, Grider JS, Pope JE, et al. Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325-1354. Published 2022 May 5. doi:10.2147/JPR.S355285.
